Dr. Sara M. Tolaney on Neoadjuvant Treatment Considerations for TNBC

Article

Sara M. Tolaney, MD, MPH, medical oncologist, Dana-Farber Cancer Institute, discusses neoadjuvant treatment considerations for patients with triple-negative breast cancer (TNBC).

Sara M. Tolaney, MD, MPH, medical oncologist, Dana-Farber Cancer Institute, discusses neoadjuvant treatment considerations for patients with triple-negative breast cancer (TNBC).

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Photo of a woman with brown hair and bangs
Photo of a man wearing a suit in front of an Oncology Nursing News backdrop
Related Content
Graphic depicting a nurse with a cell strucutre behind. Graphic by Gwendolyn Salas, MJH Life Sciences, with AI

Structure to Safety: A Nurse's Guide to Safe ADC Care

Ellen Rice Tichich, MFA, MSN, RN, NPD-BC
September 16th 2025
Article
Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
September 16th 2025
Podcast
Line illustration of a breast on a yellow background

CDK4/6 Inhibitors: How to Tailor Treatment Choices by AEs

Bridget Hoyt
September 16th 2025
Article
The Vitals

Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

Lindsay Fischer
September 16th 2025
Podcast
Icon of a breast with various clinicians using medical equipment

Personalizing CDK4/6 Inhibitor Care to Reduce Adverse Events

Bridget Hoyt
September 16th 2025
Article
Image of a person with a breast tumor

Making Breast Cancer Treatment Decisions After Endocrine Therapy

Bridget Hoyt
September 16th 2025
Article